Modified PAGE-B score classifies HCC risk in patients undergoing HBV therapy

The PAGE-B score and a modified PAGE-B score identified which patients on antiviral therapy for chronic hepatitis B had a low risk for hepatocellular carcinoma development, according to published data.
Because the PAGE-B score — a risk prediction model based on age, sex, and platelet count — was developed among Caucasian patients on HBV antiviral therapy, Terry Cheuk-Fung Yip, PhD, from the Chinese University of Hong Kong, and colleagues developed the mPAGE-B score, modified slightly by Korean investigators to include serum albumin and weighted adjustment of age, sex, and platelet

Source link

Related posts



Metformin-induced hepatokine reduces appetite


Proteomics promises a new era of precision cancer medicine


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy